Skip to main content
Premium Trial:

Request an Annual Quote

BD s Atto Bioscience to Acquire Scanalytics for $453K

NEW YORK, July 1 (GenomeWeb News) - IT vendor CSP has sold the assets of its Scanalytics subsidiary to Becton Dickinson business Atto Bioscience for $453,000 in cash, the company said today.

Scanalytics, based in Fairfax, Va., markets scientific imaging software, including deconvolution and 3D restoration and gel analysis software. Atto Bioscience specializes in optical instrumentation, software, and reagents for real-time cell analysis.

The acquisition makes sense to BD. Most recently, BD Biosciences and Scanalytics signed an alliance to co-develop image-analysis software for BD Bioscience's automated microscopy platforms.


Dietrich Ruehlmann, BD Biosciences' product manager for imaging and analysis, told GenomeWeb News at the time that BD began the partnership with Scanalytics a few months ago with the goal of developing image-analysis platforms for BD Biosciences' CARV II Confocal Imager and Pathway Bioimager for high-content drug screening.

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.